2 November 2020 - Deborah Wilkes
Premium
The US Food and Drug Administration (FDA) has switched Arbor Pharmaceuticals’ Sklice treatment for head lice from prescription-only to OTC status.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.